politics
Thailand's monkey business: Pharmaceutical labs rely on primate testing

Thailand's monkey business: Pharmaceutical labs rely on primate testing

5 Mayıs 2026France 24

🤖AI Özeti

Pharmaceutical companies heavily rely on monkeys for drug and vaccine testing. Following China's 2020 ban on primate exports, the cost of these animals has surged, leading to the emergence of a black market. This illegal trade primarily involves countries like Cambodia, Thailand, and Laos, where trafficking activities are rampant.

💡AI Analizi

The reliance on primate testing raises ethical concerns, particularly as the black market flourishes in response to regulatory changes. The spike in prices not only highlights the demand for these animals but also underscores the potential risks associated with unregulated trafficking. As the pharmaceutical industry grapples with these challenges, the need for alternative testing methods becomes increasingly urgent.

📚Bağlam ve Tarihsel Perspektif

The global pharmaceutical industry has long depended on animal testing, particularly primates, for developing new medications. The ban on exports from China has significantly impacted the availability of these animals, prompting a shift in the dynamics of the supply chain and leading to illegal activities in neighboring countries.

This article reflects the views of the authors and does not necessarily represent the views of France 24.